Participants receiving the highest dose (12 mg weekly) achieved a mean body weight reduction of approximately 24% over 48 weeks
consistent quality and solid labeling The labels are very clear and easy to read
Hashimoto's is an autoimmune condition where the immune system attacks thyroid peroxidase and thyroglobulin
However, the accelerated approval pathway means that evidence is still interim: while part one of the ESSENCE trial demonstrated improvement in liver scarring and inflammation, it does not yet show whether semaglutide reduces the risk of serious outcomes such as cirrhosis, liver failure or liver cancer
Key takeaways GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone that helps reduce appetite, regulate blood sugar levels and slow digestion
Over time, obese patients lose roughly 12% of their body weight on Wegovy (semaglutide) and about 18% on Zepbound (tirzepatide, which targets GLP-1 and another gut hormone, GIP.) Diana Thiara, MD, medical director of the UCSF Weight Management Program, says the results can be amazing and life-changing for people with obesity, a condition linked to a host of health risks
